These substances were linked to reduced decline and slight enhancement of cognitive functions in two phase III trials, although the results did not reach statistical significance [ 44 , 45 ].
← all excerpts
Prophylactic cranial irradiation for small cell lung cancer in the era of immunotherapy and molecular subtypes.
1
—
—